IONS · Categories · Downgrades
IONS - Analyst downgrades
Ionis Pharmaceuticals Inc. (IONS) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for IONS
- Ionis Pharma downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Ionis Pharma from Outperform to Market Perform and set a new price target of $60.00 from $67.00 previously
- Ionis Pharma downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Ionis Pharma from Overweight to Equal-Weight and set a new price target of $40.00 from $56.00 previously
- Ionis Pharmaceuticals downgraded by B of A Securities with a new price targetB of A Securities downgraded Ionis Pharmaceuticals from Buy to Underperform and set a new price target of $30.00 from $40.00 previously